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Abstract
Background: Although psychotherapy is considered the treatment of choice for patients with personality disorders
(PDs), there is no consensus about the optimal level of care for this group of patients. This study reports the results
from the 6-year follow-up of the Ullevål Personality Project (UPP), a randomized clinical trial comparing outpatient
individual psychotherapy with a long-term step-down treatment program that included a short-term day hospital
treatment followed by combined group and individual psychotherapy.
Methods: The UPP included 113 patients with PDs. Outcome was evaluated after 8 months, 18 months, 3 years
and 6 years and was based on a wide range of clinical measures, such as psychosocial functioning, interpersonal
problems, symptom severity, and axis I and II diagnoses.
Results: At the 6-year follow-up, there were no statistically significant differences in outcome between the treatment
groups. Effect sizes ranged from medium to large for all outcome variables in both treatment arms. However, patients
in the outpatient group had a marked decline in psychosocial functioning during the period between the 3- and
6-year follow-ups; while psychosocial functioning continued to improve in the step-down group during the same
period. This difference between groups was statistically significant.
Conclusions: The findings suggest that both hospital-based long-term step-down treatment and long-term
outpatient individual psychotherapy may improve symptoms and psychosocial functioning in poorly functioning
PD patients. Social and interpersonal functioning continued to improve in the step-down group during the
post-treatment phase, indicating that longer-term changes were stimulated during treatment.
Trial registration: NCT00378248.
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Background
Although psychotherapy is a cornerstone in the treatment
of personality disorders (PDs), there is little empirical evi-
dence regarding how different levels of psychotherapeutic
care may affect treatment outcome [1-3]. Gunderson et al.
[4] described “level of care” as a multi-dimensional
construct that includes a variety of aspects, such as
containment, intensity, the structure and duration of
treatment, and cost. From an organizational perspective,
the term “level of care” usually refers to whether treatment
is offered as inpatient hospitalization, day hospital or out-
patient treatment, regardless of the duration and intensity
of therapy or whether it is conducted in an individual or
group format. During the past couple of decades, several
studies have demonstrated that therapies offered in out-
patient, day hospital, and inpatient settings have a positive
effect on patients with PDs [2,5,6]. However, few studies
have directly compared different treatment settings.
Recently, three Dutch multi-center studies compared
treatments at different levels of care for patients with PDs.
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Their results suggested that more intensive treat-
ment in day hospital or inpatient settings had bene-
ficial outcomes compared with outpatient treatment
[7-9]. However, these conclusions should be considered
preliminary, as the allocation of patients was not based
on randomization but on the expert opinions of
clinicians.
In Europe in particular, treatment models have been
developed that combine various levels of care for pa-
tients with PDs, known as step-down programs. Such
programs consist of an initial intensive treatment in
a day hospital or inpatient setting, followed by out-
patient psychotherapy with a corresponding reduction in
treatment intensity. Existing step-down programs tend
to emphasize various group therapies or the combin-
ation of individual and group psychotherapy, and the
treatment length is typically long-term [10,11]. Many
functionally impaired patients with PDs are in need of
long-term therapy and a comprehensive and integra-
tive treatment approach [12]. Promising evidence
suggests that step-down models have the potential to
meet such needs for patients with severe PDs, par-
ticularly borderline PD [13-18]. However, only one
step-down model has been tested in a randomized
design. Fonagy and Bateman [13,14] found there
were superior effects from an 18-month mentalization-
based day treatment followed by outpatient group psycho-
therapy for another 18 months, compared with treatment
as usual. Differences in outcome were still significant at 8-
years follow-up [15]. So far, no randomized study has
compared a step-down model with outpatient individual
therapy, which appears to be the most realistic therapeutic
alternative in Western societies.
Despite the assumption that patients with severe PDs
might benefit from long-term treatment, there have been
few randomized studies of therapies lasting more than
1 year for patients with severe PDs [14,19,20]. Also, while
several studies have shown that treatment gains may be
maintained for 1 or 2 years after treatment, few studies
have investigated the long-term course of symptoms after
treatment [15,17,21]. One might assume that, for a major-
ity of patients, systematic psychotherapy would contribute
to more adaptive personality functioning and increased re-
sistance to future challenging life circumstances. However,
naturalistic follow-along studies have revealed consider-
able variation over time in the clinical course of patients
with PDs [22-25]. Therefore, we need more studies
evaluating how treatment at various levels of care might
influence the long-term course of symptoms and social
adjustment.
The Ullevål Personality Project (UPP) is a randomized
clinical trial (RCT) designed to investigate the effect of
two treatment conditions: (1) a step-down program
comprising short-term day hospital treatment followed
by a combination of long-term group and individual
psychotherapy for a maximum of 4 years, or (2) outpatient
individual psychotherapy. The results of the 8 month,
18 month and 3 year evaluation have been reported
previously [26-28]. The initial hypothesis was that the
step-down treatment program would yield better clinical
outcomes than outpatient individual psychotherapy.
However, despite the more extensive format of the
step-down treatment, results from the 18-month and 3-
year follow-up studies indicated that step-down treatment
was not more effective than outpatient individual psycho-
therapy. In fact, there was a trend towards better results
with the outpatient treatment; in particular, psychosocial
functioning from 18 month to 3 years exhibited a signifi-
cantly more favorable course in the outpatient treatment
group. Yet, at the 3 year follow-up, approximately one
third of the patients in both treatment arms were still
participating in their study treatments, with the potential
for further improvement.
This study aimed to compare long-term outcomes in
the two treatment groups using a wide range of clinical
measures. More specifically, we addressed three research
questions:
1. Are there differences in overall clinical course, from
baseline to 6 years follow-up on the primary
outcome variables, i.e., psychosocial functioning,
interpersonal problems, symptom distress, and
quality of life?
2. Are there any differences in patterns of clinical
course, on the primary outcome variables between
the 3- and 6-year follow-ups?
3. Are there any differences in secondary outcome
variables at 6-year follow-up, i.e., diagnostic status,
self-harm/suicidality, vocational functioning, and use
of health care services?
Methods
Setting and design
The UPP was conducted at the Department of Personality
Psychiatry (DPP) at Oslo University Hospital. The
State Health Insurance Fund covered the expenses for
both treatment conditions. Patients were evaluated be-
fore treatment, and after 8 months, 18 months, 3 years,
and 6 years. All patients received optional psychophar-
macological consultations with a psychiatrist as part of
the follow-up evaluations. The staff at the DPP conducted
the initial clinical and diagnostic evaluation, while PhD
students and research assistants performed the follow-up
interviews and diagnostic evaluations. Written informed
consent was obtained from participants after they were
provided with a description of the study. The Data In-
spectorate and Regional Ethics Committee in Norway
approved the project.
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Participants
Two hundred and fifty patients were referred to the DPP
at Oslo University Hospital Ullevål during the intake
period. Only patients with a diagnosis of PD were in-
cluded. Exclusion criteria were schizotypal PD, antisocial
PD, ongoing alcohol or drug dependence, psychotic
disorders, bipolar I disorder, untreated attention deficit
hyperactivity disorder (adult type), pervasive developmental
disorder (e.g., Asperger’s syndrome), organic syndromes,
and being homeless. One hundred and thirty-three patients
were excluded because they had conditions listed in the
exclusion criteria, did not have any PD, or did not
attend the baseline evaluation. The patients’ pre-
treatment demographics and clinical characteristics
are reported in Table 1. After random assignment,
there were no statistically significant differences in
socio-demographic or clinical variables between the
two groups, including the number of patients with
axis I or axis II disorders and the mean number of
axis II criteria.
Completeness of data
Figure 1 depicts the flow of patients throughout the
study. After the initial evaluation, 117 patients were ran-
domly allocated to one of the two treatment arms. Four
patients withdrew from the study at different points after
randomization. The present study included 113 patients:
59 in the step-down treatment arm and 54 in the out-
patient treatment arm. Seventy-nine participants (70% of
all participants) attended the 6-year follow-up investiga-
tion. These participants constituted 71% of the original
participants in the step-down group and 67% of the
original participants in the outpatient group (Figure 1).
At the 6-year follow-up, there was no statistically signifi-
cant difference in attendance rates between the two
treatment groups. Moreover, there were no statistically
significant differences in baseline variables between
those who did and did not attend the 6-year follow-up
analysis; however, there was a non-significant trend
among those not attending towards having a higher
score on the baseline Beck Depression Inventory (BDI)
(p = 0.057). Fifty percent of the participants completed
all five evaluations, while 4% attended only the baseline
evaluation.
Treatments
Step-down day hospital treatment (Step-down treatment)
The step-down day hospital treatment program consisted
of an initial 18-week day hospital treatment phase, with a
combination of psychodynamic and cognitive-behavioral
group therapies for 3 to 4 days each week. The written
treatment guidelines adhered to relational psychotherapy,
with references to group analysis, self-psychology, and
mentalization. After the initial day hospital treatment, the
patients continued with outpatient combined psychother-
apy. The outpatient treatment consisted of weekly group
therapy (1.5 hours) for a maximum of 4 years, combined
with weekly individual therapy for a maximum of 2.5 years.
Fourteen percent of the patients dropped out of the step-
down treatment before starting the combined outpatient
psychotherapy. The average duration of treatments in the
Table 1 Baseline patient characteristics (n = 113)
Total
(n = 113)
Step-down
(n =59)
Outpatient
(n= 54)
Mean age (SD) 31 (7.3) 31 (7.2) 31 (7.4)
Women 75% 78% 72%
Education and work status
More than 12 years of education 51% 47% 57%
Full-time employee (100%) 23% 23% 24%
Half-time employee (approx. 50%) 8% 12% 4%
Student 16% 16% 16%
Unemployed 50% 49% 50%
Other 3% 0% 6%
Symptom severity
Mean symptom distress, GSI (SD) 1.72 (0.66) 1.71 (0.69) 1.75 (0.62)
Mean interpersonal problems, CIP (SD) 1.69 (0.51) 1.70 (0.53) 1.72 (0.48)
Mean psychosocial functioning, GAF (SD) 47.6 (4.4) 47.3 (4.3) 47.9 (4.6)
Self-injury / suicide attempts
Suicidal thoughts in the last 7 days 50% 50% 50%
Suicidal thoughts in the last
12 months
85% 88% 82%
Self-injury in the last 12 months 31% 36% 26%
Axis II diagnosis
Mean number PD diagnosis 1.4 (0.6) 1.5 (0.7) 1.4 (0.6)
Mean number PD criteria 15 (5.7) 15 (6.2) 15 (5.2)
Schizotype 0% 0% 0%
Schizoid 1% 2% 0%
Paranoid 14% 17% 11%
Histrionic 0% 0% 0%
Narcissistic 2% 0% 4%
Antisocial 0% 0% 0%
Borderline 46% 46% 46%
Avoidant 41% 44% 37%
Dependent 7% 7% 7%
Obsessive-compulsive 9% 12% 6%
PD NOS 21% 19% 24%
Axis I diagnosis
Mean number axis I diagnosis (SD) 3.4 (1.4) 3.7 (1.3) 3.5 (1.5)
Mood disorders 87% 85% 89%
Anxiety disorders 87% 90% 83%
Substance abuse disorder 25% 19% 32%
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step-down group was 31 months (SD = 16), and the aver-
age number of outpatient consultations (counting both
group and individual therapy) was 106 (SD = 76.0). The
mean interval between the end of study therapy and
the 6-year follow-up analysis (post-treatment phase)
was 43 months (SD = 18).
Outpatient individual psychotherapy (Outpatient treatment)
The outpatient treatment consisted of different individual
psychotherapies conducted mainly by therapists in private
practice. The therapists were instructed to treat the patients
according to their own preferred method and practice. The
researchers gave no instructions to the therapists regarding
the duration or intensity of psychotherapy, nor did they
interfere with any treatment decisions. The average dur-
ation of treatment in the outpatient group was 24 months
(SD = 20), and the average number of consultations
was 56 (SD = 56.7). The mean interval between the end
of study therapy and the 6-year follow-up analysis
(post-treatment phase) was 47 months (SD = 20) in the
outpatient treatment.
Therapists
To recruit individual therapists to the study, letters were
sent to all therapists in Oslo with a contract with the
State Health Insurance Fund, as well as professionals
working in public mental health outpatient clinics. The
therapists were assigned to one of the two treatment
arms according to their own preferences, and signed a
formal treatment contract with the project.
Group therapists in the step-down treatment
The 10 group therapists in the day hospital treatment
were regular staff from the DPP (three psychiatric nurses,
two psychiatrists, one residential doctor specializing in
psychiatry, one specialist in clinical psychology, one art
therapist, one social worker, and one physiotherapist).
Seven of the 10 therapists had 5-years of training in group
analysis. The mean age of the therapists was 48 years
(SD = 9) and 80% were female. These therapists also
conducted the outpatient group therapy.
Individual therapists in the step-down treatment
The individual therapists (n = 30) involved in the follow-up
outpatient treatment included 16 psychologists, 12 psychia-
trists, and two psychiatric nurses. Seven were recruited
from the regular staff at the DPP. The therapists treated
between one and three patients each. The mean age of the
individual therapists was 50 years (SD = 9) and 57% were
female. Their mean work experience as psychotherapists
was 16 years (SD = 8). They were generally very satisfied
with their work as therapists; when asked to rate their
satisfaction on a scale ranging from 0 (no satisfaction) to 5
(very satisfied), the mean answer was 4.2 (SD = 0.6).
Figure 1 Patient dispensation in a randomized clinical trial comparing a step-down treatment program with outpatient treatment.
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Therapists in the outpatient treatment
Thirty-two external therapists were recruited to provide
outpatient treatment (16 psychologists, 15 psychiatrists,
and one resident). Each therapist treated one to three
patients. The mean age of these therapists was 55 years
(SD = 8) and 41% were female. The mean work experience
as psychotherapists was 20 years (SD = 8). The majority
of these therapists practiced psychodynamic theoretical
oriented therapy. At the same time, they reported being
influenced by therapeutic theory and principles from other
therapy models. They reported a mean of 4.0 (SD = 0.6)
on the satisfaction scale. The individual therapists in the
outpatient treatment arm were somewhat more experi-
enced than the individual therapists in the step-down
treatment arm (p < 0.05). The percentage of men was
somewhat higher among the therapists in the outpatient
group than among the individual therapists in the step-
down group; however, this difference did not reach statis-
tical significance.
Outcome measures
Psychosocial functioning
Psychosocial functioning was rated using the Global
Assessment of Functioning Scale (GAF) and the Work
and Social Adjustment Scale (WSAS) [29]. The GAF is
rated on a scale from 1 to 100, with a higher score indi-
cating a higher level of functioning. The GAF scores
were observer-rated according to a split symptom and
function version [30]. Only the lowest GAF scores of
symptoms and functions were used in the analyses.
The staff at the DPP rated the GAF scores at baseline;
while, research fellows conducted the GAF interviews
at the 8-month, 18-month, 3-year, and 6-year evalua-
tions. All raters were blinded concerning treatment
conditions. The reliability of the GAF scores (intra-class
correlation coefficient, ICC 2.1) was 0.56 at baseline, 0.81
at 8 months, 0.85 at 18 months, 0.94 at 3 years, and 0.92
at 6 years. The WSAS is a self-reported 5-item scale of
functional impairment. It measures level of impairment
on a scale from 0 to 8, where 0 indicates no impairment at
all and 8 indicates very severe impairment. The scores on
the five different items are totaled in a sum score (range:
0–40). Subjective Quality of Life (QoL) was assessed using
a 10-point scale, with a score of 1 representing the lowest
perceived QoL and a score of 10 indicating the highest
perceived QoL.
Interpersonal problems
Self-reported interpersonal problems were assessed by
the Circumplex of Interpersonal Problems (CIP) [31], a
48-item Norwegian version of the Inventory of Interper-
sonal Problems-Circumplex version (IIP-C) [32] with a
5-point Likert response format ranging from 0 to 4. A
higher score indicates more interpersonal problems.
The sum scores of the two versions correlate at a level
of 0.99.
Symptom distress
Self-reported symptom distress was measured by the
Symptom Checklist, SCL-90-R [33]. The SCL-90-R was
designed to cover the major symptoms of psychiatric
distress, summarized in a Global Severity Index (GSI)
with scores ranging from 0 to 4, with higher scores indi-
cating more symptom distress. Characteristic attitudes
and symptoms of depression were assessed using the
BDI [34]. Sum scores between 19 and 29 indicate moderate
depression, while scores ≥30 indicate severe depression.
Axis I and II diagnoses
Axis I and II diagnoses were based on the Mini Inter-
national Neuropsychiatric Interview (MINI) [35] and the
Structured Clinical Interview for DSM-IV (SCID-II)
[36], respectively. At the 6-year follow-up, 30 videotapes
were evaluated by two independent raters. The reliability
coefficients were (ICC 2.1) were 0.76, 0.87, and 0.92
for the number of axis I diagnoses, number of axis II
diagnoses, and total number of SCID-II criteria, re-
spectively. The diagnostic reliability at baseline and at
the 3-year follow-up were also acceptable and were re-
ported previously [28].
Self-harm, suicidal thoughts and suicide attempts
Incidents of self-harm and suicide attempts were self-
reported by patients and then confirmed during the
research interviews. At baseline and at the 6-year follow-
up, the patients were asked to report self-harm and sui-
cide attempts during the last 12 months. When assessed
at the 8-month, 18-month, and 3-year follow-ups, patients
were asked to report incidents since the last follow-up, as
well as suicidal thoughts during the last seven days.
Statistical analysis
All results were analyzed using an intention-to-treat
approach based on treatment assignments. Longitudinal
analysis was used to assess change over time and relate
the changes to covariates, particularly treatment group
assignment. We used a linear mixed model (LMM) for
the continuous outcomes, with maximum likelihood as
the method of estimation. Piecewise linear splines, with
one knot at 3-years for all outcomes, were used to
describe the main features in the observed outcomes.
Separate random intercepts and slopes were included
when proven to enhance the model fit. The parameters
of main interest were the fixed effect interaction terms
between groups and times, prior to and following the
knot, describing whether the patients in the two groups
changed differently across the observation period. As-
sumptions about withdrawal from follow-up evaluations
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(missing at random, MAR) and selection bias follow
descriptions in previous reports [28]. Although it is not
possible to test the MAR assumption, a comparison with
a complete case analysis (participants without dropouts)
is informative and was conducted in this study. When
interpreting the significance levels, it is important to
keep in mind that no correction for multiple testing was
conducted in this trial. Residual analyses and a search
for outliers were performed to assess model adequacy.
The treatment effects at the 6-year follow-up on axis I
and II diagnoses were compared using an independent
t-test (two-tailed) and chi-squared statistics. For the
analysis of vocational functioning and the estimates of
health care use, the normal distribution range was not
fulfilled and non-parametric tests were used. Within-
group pre-post effect sizes were computed using Cohen’s
d, with pooled pre- and post-SD adjustment for sample
size. All analyses were performed using SPSS (version 18;
SPSS Inc.).
Results
Overall clinical course from baseline to the 6-year follow-up
According to the LMM analyses, there were no statisti-
cally significant differences between treatment groups
at the 6-year follow-up for the primary outcome vari-
ables. The p-value of the different outcomes between
treatment conditions were: GAF (p = 0.52), WSAS (p =
0.47), CIP (p = 0.96), GSI (p = 0.38), BDI (p = 0.47), and
QoL (p = 0.27). Both groups improved on all outcome
variables between baseline and 6 years. The means and
SDs for the main outcome measures, as well as the
within-group effect sizes are shown in Table 2. The
mean effect size (d) was 1.07 (range: 0.56-1.92) in the
step-down group from baseline to 6 years and 0.87
(range: 0.66-1.10) in the outpatient group.
Clinical course from the 3- to 6-year follow-up
The LMM analyses revealed statistically significant differ-
ences in the course of psychosocial functioning (Figure 2
and Table 3). Patients in the outpatient treatment arm ex-
perienced a significantly greater increase in psychosocial
functioning between 18 months and 3 years [28]. How-
ever, during the period from 3–6 years, the level of
functioning was reversed in the outpatient group. In
contrast, there was stable growth in the level of function-
ing in the step-down group. This between-group differ-
ence was statistically significant for both GAF (p < 0.001)
and WSAS (p = 0.001), favoring the step-down treatment.
For the other outcome measures, the interaction between
treatment group and time (3–6 years) was not statistically
significant, although the difference in the course of the
CIP trended towards significance (p = 0.055) in favor of
the step-down program.
Secondary outcome variables at the 6-year follow-up
There were no statistically significant differences between
the two treatment groups at the end of the follow-up
period with respect to the numbers of patients with axis I
or axis II disorders. The step-down group had a mean
number of 1.7 (SD = 1.5) axis I diagnoses, versus 2.3
(SD = 2) in the outpatient group. Thirty percent of the
participants at the 6-year follow-up had been diagnosed
with at least one PD. The mean number of PDs was 0.45
(SD = 0.75) in the step-down group and 0.31 (SD = 0.59)
in the outpatient group. The mean number of PD criteria
met was 5.8 (SD = 6.5) in the step-down group and 5.6
(SD = 5.6) in the outpatient group.
At the 6-year follow-up, 10% of patients in the step-
down group and 12.5% of patients in the outpatient group
reported self-harming behavior in the last 12 months.
Twenty-one percent of patients in both treatment arms
reported suicidal thoughts in the past 7 days. Forty
percent of patients in the step-down group and 41% of
patients in the outpatient group reported suicidal
thoughts in the past 12 months. One patient in the
step-down group reported a suicide attempt during the
past 12 months, while no suicide attempts were reported in
the outpatient group. One patient in the step-down group
committed suicide 9 months after withdrawing from the
day hospital treatment. According to the Norwegian na-
tional registration office, two more patients (from the
outpatient treatment arm) had died. The causes of these
patients’ deaths are unknown.
At the 6-year evaluation, 61% of participants had
worked or studied at some point during the past year:
67% in the step-down group and 54% in the outpatient
group. The median number of months spent working or
studying was 7 (range: 0–12) in the step-down group
and 2 (range: 0–12) in the outpatient group. This differ-
ence was not statistically significant. However, 63% of
patients in the step-down group and 34% of patients in
the outpatient group had a GAF score >60 (p = 0.018).
The use of health care services, like contact with a gen-
eral practitioner and current outpatient treatment, did
not differ significantly between groups (Table 4). The
complete case analyses showed a similar pattern as the
intention to treat analyses. According to the complete
case analyses, there was a statistically significant difference
in the course of psychosocial functioning, as assessed by
GAF and WSAS, favoring the step-down treatment in the
3 to 6 year period.
Discussion
Summary of findings
First, there were no statistically significant differences
between the treatment groups regarding the primary
outcome variables from baseline to the 6-year follow-up.
Both groups exhibited clinical improvement during the
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6-year period. The effect sizes were mainly in the large
range for both treatment groups; although, there was a
tendency towards larger effect sizes in the step-down
treatment arm. Second, patients in the outpatient group
had a marked decline in psychosocial functioning during
the period between the 3- and 6-year follow-ups; while,
psychosocial functioning continued to improve during
the same period in the step-down group. This effect was
statistically significant. Finally, 30% of patients still had a
PD diagnosis at the 6-year follow-up, with no significant
differences between the two treatment arms. There were
also no statistically significant differences between groups
concerning self-harm/suicidality, vocational functioning,
and use of health care services.
Comparison with other studies
The findings in the present study differ from those of
other step-down programs by Chiesa et al. [18] and
Fonagy and Bateman [19], where superior outcomes
were observed for the step-down treatment. Some possible
explanations for these differences should be discussed. First,
there is considerable variety among the programs with
regard to their duration, intensity, and composition of
their respective treatment elements. Chiesa et al. [18]
investigated a model consisting of a 6-month inpatient
stay followed by 12–18 months of outpatient combined
group and individual treatment; while, the study by Fonagy
and Bateman included 18 months of mentalization-based
day hospital treatment followed by group therapy twice
weekly for a maximum of 18 months [37]. In the present
study, the initial phase was restricted to 18 weeks of day
hospital treatment. This was followed by the long-term
outpatient therapy consisting of weekly combined group
and individual psychotherapy. Second, there were notable
differences in comparison groups. Chiesa et al. compared
their step-down model to groups receiving long-term resi-
dential treatment or general psychiatric community treat-
ment. Also, it should be mentioned that the allocation to
different treatment conditions was not based on random-
ized. The comparison group in Fonagy and Batemans’
study received treatment as usual in the local community.
Thus, neither of these studies included outpatient individ-
ual therapy as a comparison group. It is difficult to make
direct comparisons between the studies due to these
differences in program characteristics and control groups.
Also, the present study included a mixed PD sample,
although schizotypal and antisocial PDs were excluded. It
is not clear whether step-down models suit certain PD
categories (e.g., borderline PD) more than others and this
should be investigated further [16]. We also need to know
more about how different levels of PD severity can affect
treatment outcome, e.g. whether patients in the most
severe end of the severity spectrum will profit from more
or less intensive treatment or psychosocial support. For
instance, Chiesa [38,39] found that more severe PD pa-
tients seemed to respond better to a less intensive
community based treatment regime than an intensive
long-term residential stay.
Table 2 Mean outcome measures (with SD) and effect sizes * (Cohens’ d) of the step-down and outpatient treatments at
baseline and at 8, 18, 3, and 6- years of follow-up
Step-down
Baseline 8 months 18 months 3- years 6- years d
GAF 47.3 (4.3) 51.5 (10.2) 53.5 (10.3) 57.7 (12.7) 62.7 (13.6) 1.92
WSAS 25.3 (7.2) 20.6 (8.6) 19 (9) 19.2 (10.6) 13.7 (11.0) 1.19
GSI 1.71 (0.69) 1.43 (0.65) 1.32 (0.75) 1.19 (0.75) 0.91 (0.72) 1.14
BDI 18.3 (8.2) 17.2 (7.6) 15.5 (10.7) 14.7 (11.3) 13,0 (11.2) 0.56
CIP 1.66 (0.53) 1.53 (0.59) 1.51 (0.6) 1.42 (0.62) 1.13 (0.68) 0.89
QOL 3.3 (1.6) 4.5 (1.6) 4.9 (2.1) 5.4 (2) 6.1 (2.3) 1.49
PDcrit 13.3 (5.6) 8.5 (6.4) 5.9 (6.5) 1.24
Outpatient
Baseline 8 months 18 months 3- years 6- years d
GAF 47.9 (4.6) 50.2 (12) 56.8 (11.7) 66.9 (12.6) 57.1 (14.5) 1.10
WSAS 24.7 (8.2) 18.9 (9.9) 15.7 (11.2) 12.6 (10.9) 18.3 (11.3) 0.68
GSI 1.75 (0.62) 1.43 (0.73) 1.23 (0.73) 1.06 (0.79) 1.12 (0.74) 0.95
BDI 19.9 (9.5) 18.5 (11.8) 16.6 (12.5) 12.2 (10.3) 13.4 (9.95) 0.66
CIP 1.72 (0.48) 1.52 (0.57) 1.25 (0.62) 1.22 (0.64) 1.32 (0.62) 0.75
QOL 3.6 (1.7) 4.4 (1.9) 5.1 (2.3) 5.9 (2.2) 5.5 (1.85) 1.08
PDcrit 13.4 (4.8) 6.0 (5.8) 5.6 (5.6) 1.53
Note. GSI: Global Severity Index; GAF: Global Assessment of Functioning; CIP: Circumplex of Interpersonal Problems; BDI: Beck depression inventory; WSAS: Social
and Adjustment Scale; QoL: Quality of Life. *Effect sizes (d) are pre-post estimates from baseline to 6- years of follow-up.
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Figure 2 Course of primary outcome variables.
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The present finding of equal long-term outcomes
should be considered in light of accumulating evidence
of the benefits of outpatient individual therapy for patients
with PDs, particularly borderline PD [20,40,41]. Also, such
benefits are not limited to specialized manualized therap-
ies. McMain [42] and Vinnars [43] compared non-manual
based treatments with manual based therapies in commu-
nity and outpatient settings and found their effects were
similar. In the UPP, the patients in the outpatient treat-
ment arm received non-manualized psychotherapy from
therapists who were instructed to treat the patients in
accordance with their usual practice.
Clinical considerations
The present findings suggest that both hospital-based
long-term step-down treatment and outpatient individual
psychotherapy with therapists with the opportunity to
practice long-term treatment may help improve symp-
toms and psychosocial in poorly functioning PD pa-
tients. Interestingly, analyses of treatment costs from
baseline to the 3-year follow-up showed no significant
differences in total treatment costs between the treatment
conditions when both costs related to study treatment and
additional psychiatric treatments were included [44]. The
present study did not include cost analyses; however, there
were small differences in the use of health care services at
the 6-year follow-up, which suggests the differences in the
overall costs between the treatment programs are minor.
Taking into account the superior psychosocial out-
come for the outpatient treatment condition at the
3- year follow-up, the divergence in the pattern of
the clinical course between the treatment groups from
the 3- to 6-year follow-ups was unexpected. The finding
at the 6-year follow-up is strengthened by the observer-
rated GAF values and self-rated WSAS scores, which
both demonstrated the same statistically significant pat-
terns between 18 months and 3 years and between 3
and 6 years. Moreover, the shift in the proportion of
patients with GAF levels >60 further supports this
pattern. A GAF score <60 is descriptive of moderate to
severe psychosocial dysfunction, and a GAF score >60
indicates a range from mild dysfunction to a high level
of functioning. At the 3-year evaluation, only one-third
of patients in the step-down group and two-thirds of
patients in the outpatient group had a GAF level >60
[28]. In contrast, at the 6-year follow-up, two-thirds of
the step-down group and one-third of the outpatient
group had a GAF level >60. This between-group difference
was not only statistically significant, but also clinically
significant.
Table 3 Fixed effects estimates in the linear mixed model
for psychosocial function from baseline to 3 years and
from 3–6 years
Outcome Fixed effects Estimates1 SE 95% CI
GAF Main effect group
Outpatient group 0.63 0.86 −1.07, 2.33
Step-down group 0 (Ref)
Main effect time
Time ≤ 3- years 0.28*** 0.05 0.18, 0.37
Time > 3- years 0.14* 0.06 0.14, 0.26
Interaction, group x
time ≤ 3- years
Outpatient group 0.21** 0.73 0.06, 0.36
Step-down group 0 (Ref)
Interaction, group x
time > 3- years
Outpatient group −0.38*** 0.10 −0.67, −0.18
Step-down group 0 (Ref)
WSAS Main effect group
Outpatient group −1.50 1.53 −4.55, 1.55
Step-down group 0 (Ref)
Main effect time
Time ≤ 3- years −0.06 0.03 −0.12, 0.01
Time > 3- years −0.14* 0.04 −0.23, 0.05
Interaction, group x
time ≤ 3- years
Outpatient group −0.10 0.05 −0.20, 0.004
Step-down group 0 (Ref)
Interaction, group x
time > 3- years
Outpatient group 0.25*** 0.07 0.11, 0.38
Step-down group 0 (Ref)
Note. GAF: Global Assessment of Functioning; WSAS: Work and Social
Adjustment Scale.
1The time unit is one month. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
Table 4 Use of health services during the past 12 months,
at 6- years of follow-up
Total
(n = 79)
Step-down
(n =42)
Outpatient
(n = 37)
Patients with GP visits 92% 93% 92%
Patient visiting GP for mental
health issues
57% 50% 65%
Median number of GP visits 4 4 5
Currently receiving psychiatric
treatment*
48% 44% 53%
Outpatient treatment 29% 21% 38%
Contact with psychiatric
emergency
3% 2% 3%
Contact with a psychiatric nurse 11% 10% 14%
Substance addiction clinic 5% 2.5% 3%
Regular psychiatric medication 43% 33% 54%
*Includes any form of psychiatric treatment (e.g., regular contact with a
psychiatric nurse, psychiatric medication, regular psychotherapy, or day
treatment at a psychiatric hospital).
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Some plausible explanations concerning the divergence
in clinical course between groups should be discussed.
First, group therapy was an essential element in the step-
down condition. Group therapy is a demanding format for
patients with PDs that activates and challenges their inter-
personal problems and emotional difficulties. The gains
may be harder to reach and slower to appear when strug-
gling with such core issues over time in therapy groups.
However, if sufficiently integrated, the experiences might
serve as a basis for further development after the end of
treatment. Next, the step-down program implied a disrup-
tion of attachments to therapists and group members after
a short intensive day treatment phase, and required that
the patients form new emotional bonds with group
members and therapists in outpatient treatment. The
attachment difficulties typical of patients with severe
PD make those patients vulnerable during transitions
between therapies. This vulnerability may have affected
their therapeutic process and caused a delay in clinical
improvement [45]. In fact, this was the view of the clinical
management, who decided to close the step-down pro-
gram in 2008 because of the results of this study. The pro-
gram was changed to an outpatient mentalization-based
treatment program without any day hospital component.
Conversely, the outpatient group might have benefitted
from the possibility of a stable and continuing attachment
relation to one therapist during the entire treatment
period, and thereby achieved faster improvement in
psychosocial adaption. Yet, the advantage observed at the
3-year follow-up was not sustained after 6 years. At the
6-year follow-up, most patients had been in the post-
treatment phase for a long time. One may speculate
whether the less intensive outpatient individual therapy
had a more supportive function in relation to psychosocial
problems, which facilitated social adjustment in the short
run for certain patients but was easier lost in the post-
treatment phase. Finally, treatment received after secession
of UPP treatment could potentially explain the differences
in clinical course between treatment arms. However, there
were no significant differences in health care services
received in the past year between groups at the 6-year
follow-up.
Strengths and limitations
The strengths of the present study are the randomized
design and the extended follow-up of long-term therap-
ies for patients with PDs. At present, both step-down
models and outpatient therapies are realistic treatment
options for the majority of dysfunctional PD patients,
and comparisons between treatments at such different
levels of care are needed. The day hospital part of the
step-down program was quite representative for short-term
day hospitals in Norway [11]. Moreover, the two treatments
were conducted in ordinary clinical settings and only a few
severe cases with complicated comorbidities were excluded,
which strengthens the external validity of the study. High
dropout rates and unstable attendance are common in the
treatment of patients with PDs, and high attrition from
follow-up evaluations may be a challenge in longitudinal
studies of this patient group. The response rate at the
6-year follow-up was approximately 70%, which is con-
sidered satisfactory. Certain limitations of the present
study should be noted, however. First, as outlined
above, missing data and violation of the MAR assump-
tion could bias the results. However, complete case
analyses support the validity of the present findings. In
addition, in the present study we did not control for
other kinds of treatments that patients may have re-
ceived during the 6-year follow-up period. Data from
the 3-year follow-up showed that treatment outside
the UPP was common for certain patients [44]. Finally,
the study did not take into account or model the pos-
sible influence of life events or other extra-therapeutic
circumstances.
Conclusion
The findings indicate that both hospital-based long-term
step-down treatment and outpatient individual psycho-
therapy with therapists who are able to provide long-term
treatment may help improve symptoms and psychosocial
functioning in poorly functioning PD patients, although
patients with schizotypal and antisocial PD were not
included in this study. The step-down group continued
to improve in social and interpersonal functioning in
the post-treatment phase, suggesting that longer-term
changes were stimulated during treatment. In concordance
with most treatment studies of patients with PDs, there
was considerable variation in outcome among the pa-
tients across treatments. We need to further improve
our understanding of various patient and treatment
characteristics that might influence the long-term course
of these patients, and whether some treatments work
better for certain patients.
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